Evidence map›Paper›PMID 33614028›Full record

ReviewTherapeutic advances in infectious disease

The role of faecal microbiota transplantation: looking beyond

Simon D Goldenberg, Blair Merrick

Abstract readReview
In one paragraph

Review in Therapeutic advances in infectious disease. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Global research onWorld journal of gastroenterology · 2022
    Article
  13. Review
  14. RecurrentInfectious disease reports · 2022
    Article
  15. The emerging potential of microbiome transplantation on human health interventions.Computational and structural biotechnology journal · 2022
    Review
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Simon D GoldenbergCentre for Clinical Infection & Diagnostics Research, King's College London and Guy's & St. Thomas' NHS Foundation Trust, 5th floor, North Wing, St Thomas' hospital, Westminster Bridge Road, London, SE1 7EH, UK.ORCID https://orcid.org/0000-0002-6061-6064
Blair MerrickCentre for Clinical Infection & Diagnostics Research, King's College London and Guy's & St. Thomas' NHS Foundation Trust, London, UK.ORCID https://orcid.org/0000-0003-0837-7382

Funding

Department of Health PB-PG-0418-20007
6 · The paper itself

Abstract

Faecal microbiota transplantation (FMT) is the transfer of screened and minimally processed faecal material from a 'healthy' donor to 'diseased' recipient. It has an established role, and is recommended as a therapeutic strategy, in the management of recurrent

Indexed as

clostridioides difficile infection (CDI)dysbiosisfaecal microbiota transplantation (FMT)inflammatory bowel disease (IBD)irritable bowel syndrome (IBS)liver disease

Identifiers

PMID33614028
PMCPMC7841662

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.